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Introduction: There is a need for early diagnostic techniques for Parkinson’s disease (PD) as well as a means to track its course and response to 
experimental therapies. Following Braak et. al's hypothesis [1], it is thought that PD pathology spreads through transmission of pathogenic forms of α-
synuclein protein in a caudal-rostral manner. However, to date there is no synuclein radioligand to follow this process. In addition to abnormal synuclein 
aggregation (which can manifest as Lewy pathology), there is iron deposition, gliosis and neuronal loss that occurs in PD. MRI, which can image brain 
structures as well as brain function, could conceivably map changes in tissue composition, microstructure and functional connectivity and thereby 
provide a comprehensive characterization of the PD brain. In this work we employed MRI modalities that are specifically sensitive to various brain tissue 
properties, such as microstructural integrity, iron loads, and functional connectivity. Namely, we used diffusion tensor imaging (DTI), novel rotating frame 
relaxation mapping methods including adiabatic T1ρ, T2ρ  [2] and RAFF4 (Relaxation Along a Fictitious Field in the rotating frame of rank 4)[3], and 
quantitative susceptibility mapping (QSM) [4]. Finally, we acquired resting state fMRI (rsfMRI) data [5] with the goal of correlating functional with 
microstructural information.  
Materials and Methods:  Three mild-moderate advanced (Hoehn & Yahr Stage I-II; on medications) individuals with PD and three age matched healthy 
controls participated in this study and underwent MRI scanning. Scans were performed on a 3 T/ 90 cm bore, Siemens Prisma console, 64-channel 
receive system. Adiabatic T1ρ, T2ρ and RAFF4 measurements were collected from a 30 AC-PC aligned oblique axial slices between the brainstem and 
basal ganglia, whereas T1-weighted, T2-weighted images, DTI, QSM and rsfMRI were collected throughout the brain. For T1ρ, T2ρ and RAFF4 
acquisitions, 30 slices in the midbrain-region were acquired with segmented GRE readout (4 segments), voxel size: 1.6 x 1.6 x 3.6 mm3, GRAPPA= 3, 
TE=3.18 ms; TR=2s. For adiabatic relaxation measurements, Hyperbolic Secant (HS) pulses were used, with R=10, BW=1.6 kHz, pulse duration Tp= 6 
ms, ω1max /(2π) = 800 Hz, 5 acquisitions with number of pulses = 0, 4, 8, 12, 16, MLEV4 phase cycling; for RAFF4, Tp was 4.56 ms for one P-packet, 
number of P-packets 0, 4, 8, 12, 16, ω1max /(2π) =323 Hz. Parameters for QSM were: voxel size: 1.6 x 1.6 x 1.6 mm3, 96 slices, TR=51 ms, TE=10, 19, 
27, 36, 45 ms, GRAPPA 3; Flip Angle 15o; for DTI: 128 directions, with 5 additional non-diffusion weighed (b0) images, b-value=1500s/mm
2, voxel size 
1.8x1.8x1.8mm3, TR=2820 ms, TE=72.6 ms; multi band (MB)=4; for rsfMRI: EPI, TR=900 ms, multi band (MB)=4; TE=30 ms; voxel size=3 x 3 x 3 mm3, 
matrix size=64x64, 48 AC-PC aligned single oblique axial slices with interleaved slice acquisition, 502 volumes. Seed analysis from each of the defined 
ROIs was performed to extract functional connectivity measures. The various MRI parameters were calculated from a set of 26 brain areas relevant for 
PD (Fig. 1A), and compared among the subject groups. 
 
Results and Discussion:  
   
 
Figure 1. 3D 
rendered and 
multislice images 
with superimposed 
ROIs used for 
extracting MRI 
metrics from different 
MRI modalities (A); 
Relaxation time 
constants maps for 
RAFF4, T1ρ, T2ρ, and 
T2* (B-D), fractional 
anisotropy, FA, 
obtained from DTI 
(E), and correlation 
maps (F) from 
rsfMRI.   
 
Representative maps from one control subject are shown in Fig. 1. RAFF4 was 
found to have greater sensitivity than T1ρ, T2ρ, T2* and DTI to detect differences in 
several ROIs (such as caudate, thalamus and brainstem)(Fig. 2). T1ρ also 
differentiated between PD and controls in the same areas, and both RAFF4 and T1ρ 
methods exceeded other MRI techniques (e.g., FA and T2*) in differentiating PD 
from controls. The chosen MRI methodologies provide quantitative measures of a 
variety of relaxation, diffusion and susceptibility parameters which allow robust 
characterization of the microstructural properties and iron content of the brains of our 
subject populations.  Functional connectivity measures did not show differences 
between the subject groups, likely due to the limited number of subjects studied so 
far or related to the possibility that PD subjects were scanned while on their 
antiparkinsonian medications.  
Conclusion: These results demonstrate the feasibility of adiabatic T1ρ, T2ρ and 
RAFF4 to characterize the microstructural integrity and functional connectivity of PD 
subjects compared to healthy controls.  
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Figure 2. RAFF4 relaxation times measured in PD and 
controls in different areas of the brain. Data are mean ± 
SEM; left and right ROIs (where applicable) were pooled. 
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